Clinical Value of Capecitabine-Based Combination Adjuvant Chemotherapy in Early Breast Cancer: A Meta-Analysis of Randomized Controlled Trials

Capecitabine has consistently demonstrated high efficacy and acceptable tolerability in salvage chemotherapy for advanced breast cancer. However, there remains no consensus on its role in adjuvant chemotherapy for early breast cancer (EBC). To estimate the value of capecitabine-based combination adj...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Guanling, Guo, Zhaoze, Liu, Minfeng, Yao, Guangyu, Dong, Jianyu, Guo, Jingyun, Ye, Changsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841120/
https://www.ncbi.nlm.nih.gov/pubmed/28337954
http://dx.doi.org/10.3727/096504017X14897173032733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841120/
https://www.ncbi.nlm.nih.gov/pubmed/28337954
http://dx.doi.org/10.3727/096504017X14897173032733

Ejemplares similares